Storyline
15 slides
15 slides
1 slide
Accelerating treatments for rare diseases using AI-powered and patient-inspired solutions.
1 slide
Rare diseases affect 400 million people worldwide, but 95% of these diseases don't have an approved treatment.
1 slide
Our mission is to bring 100 rare disease treatments towards the clinic by 2025.
3 slides
Healx uses AI to repurpose and combine existing drugs, significantly reducing the time, cost, and risk of drug discovery, thereby developing faster, cheaper, and safer treatments for rare diseases.
3 slides
Our AI-powered product 'Healnet' leverages a comprehensive knowledge graph to transform data into actionable drug discovery insights, facilitating combination therapies, biomarker discovery, and drug repurposing.
2 slides
Our therapeutic pipeline shows multiple ongoing projects across various stages, from in silico discovery to clinical trials.
4 slides
Our seasoned leadership and collaborative board bring decades of drug discovery, scientific expertise, and strategic partnerships, driving our innovation in healthcare.
